• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Benzac Gel 5%
    / Rafa


    Active Ingredient

    Status in Israel
    OTC

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Gel

    15 g

    full basket chart 58561 2569

    Gel

    60 g

    full basket chart 9519 2098

    Gel

    GSL: 60 g

    full basket chart 24636

    Related information


    Dosage

    To be adapted according to treatment response and individual tolerance.
    In general, 1 to 2 daily applications.
    Benzac 2.5 % and Benzac 5 % should preferably be used in the following cases:
    – for emerging acne in teenagers,
    – In subjects with sensitive skin, notably children and blond-haired or red-haired subjects,
    – at the start of treatment, during a trial period, to ensure that the product is well tolerated,
    – for maintenance treatment of acne scars.
    1 application every 2-3 days as maintenance treatment for Benzac 2.5 % and Benzac 5 %.
    Apply Benzac by massaging gently with the fingertips until fully absorbed.
    Wash hands after use.
    Keep away from heat and flame.


    Indications

    For the topical treatment of acne vulgaris.


    Contra-Indications

    Patients with known hypersensitivity to benzoyl peroxide or to any of the excipients.


    Special Precautions

    For external use only.
    Specific information for patients may prevent early and unjustified interruption of treatment.
    This product may cause mild irritation (slight burning sensation, redness and desquamation of the skin), especially at the beginning of treatment. It does not indicate intolerance or allergy to the topical treatment as long as it remains moderate. However, individual sensitivity should be determined by a patch test (repeated applications to a small area of the skin for 10 to 15 consecutive days).
    To reduce irritation as much as possible:
    – Do not apply to skin irritated by previous treatment or sunburned skin.
    – As a general rule, avoid concomitant use with other topical keratolytic or detergent treatments.
    – Use a gentle soap (do not cleanse more than twice a day), and avoid using cosmetics and perfumed or alcohol-based products.
    – Do not expose the skin to sun at the start of treatment; a sunscreen should be used thereafter.
    – Do not use UV lamps.
    – Caution should be exercised in subjects with a fair complexion and in more sensitive areas (face, neck, bust, subclavicular hollow).
    – Avoid contact with the eyes and eyelids, mouth, nostrils and mucous membranes. In the event of accidental application to the mucous membranes (eyes, mouth and nostrils) or the eyelids, rinse thoroughly with water.
    – If irritation becomes unpleasant, space out applications and/or use the less concentrated form.
    – If unpleasant irritation persists despite following the precautions of use, the treatment should be discontinued.
    – Due to risk of heightened sensitivity, this medicine should not be applied to damaged skin (wounds, skin erosion or acute skin inflammation).
    – Coloured materials (such as hair or dyed fabric) that come into contact with Benzac may be bleached or discoloured.
    – This medicine contains propylene glycol and may cause skin irritation.


    Side Effects

    Very common: Dry skin, erythema, desquamation (peeling skin), burning sensation of the skin.
    Common: Pruritus, skin irritation (irritative contact dermatitis).
    See prescribing information for full details.


    Pregnancy and Lactation

    Pregnancy: Benzac gel should not be used during pregnancy unless absolutely necessary.
    Lactation: In the absence of data on excretion of benzoyl peroxide in animal or human milk, and as a number of medicinal products are excreted in human milk, benzoyl peroxide should be used with caution in breastfeeding women, and the preparation must not be applied to the chest, to prevent transfer to newborns.


    Overdose

    Benzoyl peroxide gel is indicated for topical treatment only. No systemic effects are expected due to excessive application of the product. Excessive topical application of benzoyl peroxide does not produce better or more rapid results, and may lead to severe irritation. In this case, treatment must be interrupted and symptomatic treatment initiated.
    The appropriate measures should be taken to treat symptoms in the event of accidental ingestion.


    Manufacturer
    Galderma
    CLOSE